Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.
Despite enzyme replacement therapy, disease progression is observed in patients with Fabry disease. Identification of factors that predict disease progression is needed to refine guidelines on initiation and cessation of enzyme replacement therapy. To study the association of potential biochemical a...
Saved in:
Main Authors: | Maarten Arends, Marieke Biegstraaten, Derralynn A Hughes, Atul Mehta, Perry M Elliott, Daniel Oder, Oliver T Watkinson, Frédéric M Vaz, André B P van Kuilenburg, Christoph Wanner, Carla E M Hollak |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182379&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation
by: Derralynn Hughes, et al.
Published: (2023-04-01) -
Cardiomyopathy and kidney function in agalsidase beta‐treated female Fabry patients: a pre‐treatment vs. post‐treatment analysis
by: Christoph Wanner, et al.
Published: (2020-06-01) -
Automated electronic health record-based screening for Fabry disease in unexplained left ventricular hypertrophy (FAPREV-HCM)
by: Christoph Wanner, et al.
Published: (2025-01-01) -
Faber’s Maple: Acer fabri
by: Gary W. Knox
Published: (2014-02-01) -
Fabry Disease and Early Stroke
by: U. Feldt-Rasmussen
Published: (2011-01-01)